Performance - October finished with the threat of a second lockdown looming over the UK as COVID-19 cases continued to rise. However, this did not dampen demand for shares in some of the companies that have already been battered during the pandemic, even before news of a potential vaccine breakthrough broke in early November.
Valuation moves - Portfolio valuations continued to be hit by the impact of COVID-19, translating into NAV falls.
Corporate activity - Almost £500m was raised, including a new float.
Major news stories - A significant tender offer was tabled for a stake in a REIT.
QuotedData you with provides access to research on Investment Companies, Investment Trusts and Mining companies. Our aim is to provide you all the information you might need to make your own investment decisions. We cannot offer you advice on your investments.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.